High-dose cannabidiol for chronic neuropathic pain associated with spinal cord injury: a randomised clinical trial.

Robertson RV, Suraev A, McCartney D, Peng A, Meylakh N, Gordon R, Tinoco-Mendoza FA, Morse C, Sattarov L, Boswell-Ruys CL, Keay KA, Cairns EA, Shetty S, McGregor IS, Henderson LA

Open source

DOI
10.1016/j.eclinm.2026.103986
Published
2026 Jun
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.103986,
  title = {High-dose cannabidiol for chronic neuropathic pain associated with spinal cord injury: a randomised clinical trial.},
  author = {Robertson RV and Suraev A and McCartney D and Peng A and Meylakh N and Gordon R and Tinoco-Mendoza FA and Morse C and Sattarov L and Boswell-Ruys CL and Keay KA and Cairns EA and Shetty S and McGregor IS and Henderson LA},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.103986},
  url = {https://doi.org/10.1016/j.eclinm.2026.103986}
}

RIS

TY  - JOUR
TI  - High-dose cannabidiol for chronic neuropathic pain associated with spinal cord injury: a randomised clinical trial.
AU  - Robertson RV
AU  - Suraev A
AU  - McCartney D
AU  - Peng A
AU  - Meylakh N
AU  - Gordon R
AU  - Tinoco-Mendoza FA
AU  - Morse C
AU  - Sattarov L
AU  - Boswell-Ruys CL
AU  - Keay KA
AU  - Cairns EA
AU  - Shetty S
AU  - McGregor IS
AU  - Henderson LA
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.103986
UR  - https://doi.org/10.1016/j.eclinm.2026.103986
ER  - 

APA

RV, R., A, S., D, M., A, P., N, M., R, G., FA, T., C, M., L, S., CL, B., KA, K., EA, C., S, S., IS, M., & LA, H. (2026). High-dose cannabidiol for chronic neuropathic pain associated with spinal cord injury: a randomised clinical trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.103986

Source records